PrEP

Thousands of British Columbians benefiting from no-cost HIV prevention treatment: Health Minster

VANCOUVER (NEWS 1130) – More than 2,000 people in this province have benefited from the expanded coverage of drugs that can prevent HIV infection. Health Minister Adrian Dix called BC’s treatment “world-leading” at an announcement this morning. “There are an estimated 7,271 British Columbians living with HIV today. Preventing new infections and giving people the […]

Thousands of British Columbians benefiting from no-cost HIV prevention treatment: Health Minster Read More »

B.C. celebrates wide uptake of HIV prevention drugs 6 months after public funding

Six months after the B.C. government expanded funding for HIV/AIDS prevention drugs, provincial officials and health care workers are celebrating a wide uptake of the prevention regimens. In the first half of the year, more than 2,000 people were prescribed the potentially life-saving medications at no out-of-pocket cost. “We’re trying to set an example for

B.C. celebrates wide uptake of HIV prevention drugs 6 months after public funding Read More »

BC Gov expanding coverage for HIV pre-exposure throughout the province

The Health Ministry is celebrating what they are calling six-months of success in preventing new HIV infections throughout BC. At the start of this year, the government expanded coverage for HIV pre-exposure prophylaxis(pep), which has been prescribed to over two-thousand residents. In celebration of this, the province and the BC Centre for Excellence in HIV/AIDS

BC Gov expanding coverage for HIV pre-exposure throughout the province Read More »

Celebrating six months of success preventing new HIV infections throughout B.C.

People throughout B.C. are benefiting from expanded coverage for HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP), as strong uptake for the publicly funded drug continues to grow. “The expansion of coverage for PrEP and PEP keeps B.C. at the forefront of fighting the spread of HIV and AIDS,” said Adrian Dix, Minister of Health.

Celebrating six months of success preventing new HIV infections throughout B.C. Read More »

Celebrating six months of success preventing new HIV infections throughout B.C.

PEOPLE throughout B.C. are benefiting from expanded coverage for HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP), as strong uptake for the publicly funded drug continues to grow. “The expansion of coverage for PrEP and PEP keeps B.C. at the forefront of fighting the spread of HIV and AIDS,” said Adrian Dix, Minister of Health.

Celebrating six months of success preventing new HIV infections throughout B.C. Read More »

Over 2,000 people prescribed HIV prevention drug since B.C. fully funded it, health minister says

Since the start of 2018, more than 2,000 people have been prescribed a potentially life-saving drug to prevent new HIV infections in B.C. That’s according to B.C. Health Minister Adrian Dix, who says the province continues to lead the way in the global fight against the disease. The cutting-edge strategies are called PrEP and PEP,

Over 2,000 people prescribed HIV prevention drug since B.C. fully funded it, health minister says Read More »

Six months in, province celebrates uptake for free HIV prevention drugs

VANCOUVER-The Ministry of Health is reporting strong success six months into a program expanding coverage of HIV prevention medications. On Jan. 1, the province began covering the costs of preexposure prophylaxis treatment, also known as PrEP, for patients deemed at-risk. On Tuesday, Minister Adrian Dix announced that so far 1,944 people have received free PrEP,

Six months in, province celebrates uptake for free HIV prevention drugs Read More »

Implants for Delivery of Antiretroviral Drugs for HIV Pre-Exposure Prophylaxis

Strategies to reduce new HIV infections span multifaceted efforts, including safe-sex counseling, voluntary medical male circumcision, treatment as prevention, and pre- (PrEP) and postexposure prophylaxis. PrEP entails the use of antiretroviral (ARV) drugs prophylactically by HIV-negative individuals at risk of infection to thwart acquisition of the virus. In 2012, the US Food and Drug Administration

Implants for Delivery of Antiretroviral Drugs for HIV Pre-Exposure Prophylaxis Read More »